Childhood Cancers Flashcards

1
Q

Chemo agents + Long term effects

A

Doxorubicin- Cardiotoxic
Cisplatinum - Nephrotoxic and Ototoxic
Carboplatinum -nephrotoxic
Vincristine - Neurotoxic
Etoposide - Secondary malignancy
Dactinomycin - Hepatotoxic ( Veno - occlusive disease of liver)
Bleomycin - Pulmonary toxicity (fibrosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Treatment of Tumor Lysis

A

Preventative: Hyperhydration - 2.5 L/m2 of IV fluid, allopurinol or urate oxidase (Rasburicase)

Phosphate excretion: Aluminum hydroxide

Treat symptomatic hypercalcemia
Dialysis if progressive renal failure, K>6mEq/l, PO4 >6mg/dl, Oliguria, Anuria and volume overload, symptomatic hypocalcemia, hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hyperleukocytosis

A

WCC >100 x 10^9/l
More common in AML than ALL

Clinically significant hyperleukocytoses
WCC> 200x10^9/l
AML - >50x 10^9/l

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Signs and Symptoms of Hyperleukocytosis

A

CNS - Vision loss, diplopia, delirium, stupor, papilledema, coma
RS - Orthopnea , Dyspnea, Tachypnea, Hypoxia
Genitourinary- Oliguria, anuria, priapism
DIC, retinal hemorrhages, renal vein thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Management of patients with Hyperleukocytosis

A

Supportive care: Hyper-hydrate with 2.5-3 L/m2 of fluid, prevent TLS, give allopurinol/rasburicase.

If patient is asymptomatic, do chemotherapy

If patient is symptomatic or TLC >300,000/mm3 (AML) or >100,000mm3 (ALL)- Chemotherapy + Leukapheresis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Management of patients with Hyperleukocytosis

A

Coagulopathy correction
Asymptomatic patients: HB>6-7 g/dl: No RBC transfusion
Hb<5-6g/dl or signs of Congestive heart failure: RBC transfusion

Symptomatic
Platelets <20000/mm^3 - Platelets transfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Management of Hyperleukocytosis

A

Hyper-hydration - N/S (0.9%) at 3l/m2 IV. Monitor urine output
Start allopurinol 100mg/m2/day in divided doses
Platelet transfusion if platelet count <20 and reduce risk of IntraCranial Hemorrhage

Whole blood transfusion only if symptomatic anaemia or Hb<6. avoid packed cells - causes hyper viscosity
FFP transfusion with Vit K if coagulopathy present
Exchange blood transfusion (Leukopheresis)
Start steroids for acute leukemia, NHL
Hydroxyurea in CML/AML
Start chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Management of Febrile Neutropenia

A

Blood cultures
Urinalysis and culture
Culture of septic lesions
CSF culture if there’re signs of meningism
CXR if respiratory signs
Give Ceftriaxone and Gentamycin - 1 line
Meropenam - 2 line
Vancomycin- 3 line

If there’s prolonged FN >96 hours - invasive fungal infection
Or viral infection or TB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Good prognostic indicators for ALL

A

Age - 1 to 9
WBC x10^9 - 10
Immunophenotype - Pre-B cell
Genetics - Hyperploidy, DNA index >1.16
CNS Status - CNS 1
Race - Caucasians
Sex - Female
Organomegaly - Absent
Mediastinal mass - Absent
Response to early treatment- Rapid
MRD( end of induction) - <0.01

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Intermediate Prognostic factors for ALL

A

Age - <10^a
WBC x10^9 - >/= 50^a
Immunophenotype - T cell
Genetics - Diploid
CNS Status - CNS 2^a
MRD( end of induction) - 0.01 to 0.99%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Unfavorable prognostic indicators for ALL

A

Age - <1 and MLL+
Genetics - Hypoploidy <44 DNA<1.16
CNS Status - CNS 3
Race - Black
Sex - Male
Organomegaly - Present
Mediastinal mass - Present
Response to early treatment- Slow
MRD( end of induction) - <1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Treatment of ALL

A

Start with good counselling about condition and treatment (takes 2 years)
Supportive care – packed cells, platelet transfusion.
High fever/Febrile neutropenia and possible septicaemia-antibiotics with Blood cultures.
Allopurinol 10mg/kg/day
Fluid intake of 2-3L/m2/day
Manage hyperleukocytosis
Support to prevent and ameliorate tumour lysis syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Differential Diagnosis of ALL

A

AML
Aplastic anaemia
Myelofibrosis
Infectious mononucleosis
Juvenile idiopathic arthritis
Osteomyelitis
Infiltration of the bone marrow- neuroblastoma, rhabdomyosarcoma, Ewing sarcoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Laboratory Investigations for ALL

A

FBC and blood film comment (Blasts in peripheral blood)
Bone marrow aspirates and trephine- Morphology (Blast >25%), histochemistry, immunophenotyping, cytogenetics.
Chest x-ray - Mediastinal mass
Blood chemistry – LFTs and RFT
CSF – blasts and cells (Lumbar Puncture)
Coagulation profile
HIV screen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment Strategies of ALL - Induction and Consolidation

A

Induction: usually in Haematologic malignancies. A combination of high dose drugs to induce complete response when initiating a curative regimen(Vinc, Doxo, L-Aspar, Steroid, IT MTX/Ara C - MAVDAS)

Consolidation: given after induction has achieved a complete remission. Prevents re-proliferation of leukaemic cells. Repeated to increase cure rate or prolong survival. (Ara C, Cyclo, Doxo, Etop - CADE)

Ara-C is cytarabine
IT-MTX - Methotrexate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment Stategies for ALL - Delayed Intensification and Maintenance

A

Intensification: after complete remission is achieved, same agents used in induction or diff agents are given at high doses to effect better cure rate or longer remission (Repeat Induction and Consolidation)

Maintenance: Combination, low dose given on long term basis in remission to prevent re-growth of residual cancer cells( 6MP, MTX, Vinc, steroids for 2 – 3yrs. Females - 2 y. Males - 3 y
MMVS

6MP - Mercaptopurine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Acute Complications from ALL Treatment

A

Tumour lysis syndrome
Renal failure
Sepsis
Bleeding - ‘cause of low thrombocytes from treatment
Thrombosis
Encephalopathy
Seizures
Typhilitis- neutropenic enterocolitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Chronic Complications of ALL Treatment

A

Secondary malignancy
Short stature
GH deficiency
Learning disability
Cognitive defects
Neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Presenting features of AML

A

Leukemia Cutis
Gingival hypertrophy
Chloroma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Predisposing factors to AML

A

Down’s syndrome
Fanconi anaemia
Diamond-Blackfan syndrome
MDS and myeloproliferative syndrome
Ionizing radiation treatment
Chemotherapy- Cyclo, ifosfamide, etoposide, chlorambucil.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

When is the prognosis for AML poor?

A

WBC > 100,000/mm3
2o AML - For example following treatment of ALL with etoposide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

When is prognosis for AML good?

A

Down syndrome
M3 Subtype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How is AML treated?

A

*Ara-C, Doxorubicin. Etoposide (CED), Triple Intrathecal Therapy (Methotrexate/Hydrocortisone/Cytarabine)
*All Trans Retinoic Acid for M3
*High dose cytarabine
*Stem cell transplant for relapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the cytogenic abnormality in CML?

A

Cytogenic Abnormality - Presence of Philadelphia Chromosome, which results from the translocation of chromosomes 9 and 22 (t(9;220) resulting in BCS-ABL fusion protein.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What are the clinical features in the Chronic Phase of CML?
Chronic phase lasts for approximately 3 years if untreated. Hyperleukocytosis with weakness, fever, night sweats, bone pain, respiratory distress, priapism Left upper quadrant pain (splenomegaly) +/- hepatomegaly
26
What are the clinical features in the Accelerated Phase of CML?
Characterized by progressive splenomegaly, thrombocytopenia, and increased percentage of peripheral and bone marrow blasts(10-19%)
27
What are the clinical features of the blast crisis of CML?
Bone marrow shows greater than 30% blasts and clinical picture is indistinguishable from acute leukemia. Two-thirds of blast crisis is myeloid Patients in blast crisis will die within a few months.
28
What is the first line treatment of CML?
Used to be hematopoietic stem cell transplant. Now, hydroxyurea/busulfan is given for cytoreduction Then imatinib (Tyrosine kinase inhibitor - has reduced the yearly risk of CML progression. Works on BCR-ABL)
29
Describe the classification of Lymphomas
Lymphomas: Non-Hodgkin and Hodgkin's Lymphoma Non-Hodgkin's Lymphoma: Lymphoblastic, Small Non Cleaved Cell (SNCC) and Large Cell Lymphoblastic - B cell and T cell. For SNCC - Burkitt's and High Grade B cell. For Large Cell - Anaplastic large cell and diffuse B cell large cell lymphoma.
30
What is the commonest childhood cancer in Tropical Africa?
Non-Hodgkin's lymphoma
31
What is NHL?
Malignant solid tumour of B or T lymphocytes
32
When do over 90% of patients with NHL present?
Between the ages of 4 to 9 and peak age at 5yrs. Rare below 2 yrs and above 16yrs.
33
Which groups of people are more affected? And when is the prognosis good? What is unique about the symptoms
Males are affected more than females 2:1 Prognosis is good with minimal therapy in early stages. Symptoms at presentation depends on location of the tumour
34
Clinical Presentation of Burkitt's Lymphoma of Jaw (Endemic)
Neck/jaw mass, involving nasopharynx, sinuses, Intra-oral extension Painless or painful Proptosis Teeth displaced - Called Dental Anarchy Swallowing +/- breathing difficulty (because nasopharynx is affected)
35
Clinical Presentation of Abdominal B cell Burkitt's Lymphoma (Sporadic)
Abdominal mass +/- ascites Abdominal pain Nausea and vomiting, constipation +/- bowel obstruction Urinary retention Neurological symptoms including paraplegia from pressure on spinal cord
36
Clinical Presentation of T cell Lymphoblastic Lymphoma
Cough, Stridor, Breathlessness Symptoms relating to anterior mediastinal mass +/- pleural effusion +/- SVC obstruction Lymphadenopathy Hepatosplenomegaly
37
Differentiation Between Endemic and Sporadic Burkitt's Lymphoma
Age: 5-10 y (Endemic), 6-12 y(Sporadic Sex: M>F (Endemic), M>F (Sporadic) Disbn of Dx: Africa, Brazil, Turkey (Endemic). North America, Europe (Sporadic) Annual Incidence: 10 in 100,000 (Endemic), 0.2 in 100,000 (Sporadic) Tumor sites: Jaw, Abdomen, CNS, CSF (Endemic) and Abdomen, marrow, lymph nodes, ovaries (Sporadic) Histopathologic features -Both have Starry sky appearance Presence of EBV DNA in tumor cells - 95% (Endemic), 15% (Sporadic)
38
Clinical Features of Burkitt's Lymphoma
Rapidly growing tumour of the jaws or abdomen in a high risk group (by age or location) Doubling time of 24hrs A longer history makes the suspicion less A diagnosis can only be confirmed by biopsy and histology
39
Sanctuary Sites for Burkitt's Lymphoma -
If Burkitt's lymphoma is found at these sites prognosis is not good/ there's an increased risk of relapse. Testes, Breasts, Thyroid gland, Skin, Epidural space, Bone Pancreas
40
Blood tests FBC – Rule out leukaemia (Blood film comment). Hb, WBC and Platelet count. Renal and liver function tests ( Renal function deranged with NHL and tumor lysis syndrome) LDH – raised in NHL (Highly proliferative Ca. that releases LDH on breakdown) Uric acid – raised in high tumour burden HIV screening Radiology/imaging CXR : mediastinal mass (which poses a risk of SVC syndrome) Abdominal and/or neck USS CT scan (extent of mass) MRI – not critical Echo - 'cause of use of cardiotoxic drugs (look at ejection fraction before giving drugs)
41
Other Investigations for NHL
Use least invasive method to obtain tissue Ideally a piece of solid tissue (or Needle biopsy) Pleural or ascitic fluid (check for malignant cells) Bone marrow aspirates + trephines - for diagnosis and staginng Lumbar Puncture – CNS status CNS +ve if blasts/lymphocytes in CSF or cranial nerve palsy or intracerebral mass or intraspinal mass Histopathology Scattered diffusely among the tumour cells are giant phagocytic macrophages Macrophages have retracted cytoplasm thereby creating empty spaces between the cell and adjacent tissue Characteristic starry-sky pattern - for Burkitt's
42
Staging of Burkitt's Lymphoma
A A single extra-abdominal tumour site B Multiple extra-abdominal tumour sites AR Completely (>90) resected intra-abdominal tumour (seen intraop and resected) C Intra-abdominal tumour without involvement of other sites D Intra-abdominal and extra-abdominal tumour sites
43
ST Judes Staging System for NHL - Stages 1 and 2
I A single tumor (extranodal) or single anatomic area (nodal) with the exclusion of mediastinum or abdomen. II A single tumor (extranodal) with regional node involvement. Two or more nodal areas on the same side of the diaphragm. Two single (extranodal) tumors with or without regional node involvement on the same side of the diaphragm. A primary GI tract tumor, usually in the ileocecal area, with or without involvement of associated mesenteric nodes only.
44
St Judes Staging for NHL - Stage III and IV
III Two single tumors (extranodal) on opposite sides of the diaphragm. Two or more nodal areas above and below the diaphragm. All the primary intrathoracic tumors (mediastinal, pleural, thymic). All extensive primary intra-abdominal disease. All paraspinal or epidural tumors regardless of other tumors site(s). IV Any of the above with initial CNS or bone marrow involvement.
45
Treatment of Burkitt's Lymphoma - Prephase
Cycle 1/Prephase – Oral medication with Cyclophosphamide, Prednisolone and Allopurinol Alternate cycles of Vincristine, Doxo, Cyclophosphamide, Prednisolone, IT with Cytarabine, Vincristine Cyclophosphamide, Prednisolone, IT Give every 3 weeks Minimum of 6 cycles and max of 10 cycles Give in small doses to prevent TLS. Hydrate patient
46
What factors are considered important for prognosis
Tumour burden Bone marrow involvement CNS involvement Presentation above age 13yrs. Overall response rate to chemotherapy is about 90% Relapse shortly after remission (3months) has poor prognosis
47
What is the most common primary renal tumor of childhood?
Wilm's tumor/Nephroblastoma
48
At what age is Wilm's tumor mostly diagnosed? What is the common type -
At 1-5 years with peak incidence of 3-4 years Median age of presentation - 3 years 6 months in unilateral disease and 2 years 6 months in bilateral Common type - Sporadic (1% familial)
49
Signs and symptoms of Wilm's tumor
Palpable mass in abdomen - flank mass that doesn't cross the midline) Hypertension - from hyper reninemia Hematuria Weight loss Obstipation - difficulty defecating Urinary tract infection Diarrhea Previous trauma Other S & S-nausea abdo pain
50
Associated Congenital anomalies of Wilm's tumor
Occur in 12-15% of cases WAGR syndrome – wilm’s tumour, aniridia, genitourinary malformations and mental retardation Denys-Drash Syndrome- wilm’s tumour, early renal failure with mesangial sclerosis and pseudohermaphroditism Beckwith-wiedemann syndrome-visceromegaly with hemihypertrophy, macroglossia, abdominal wall defects etc. Wilm’s, hepato, neuro, rhabdo and adrenocortical carcinoma.
51
Paraneoplastic syndromes associated with Wilm's Tumor
Thrombocytosis usually present Bleeding diathesis due to presence of acquired von Willebrand disease – prolonged bleeding time, decreased FVIII levels Hypertension Erythropoietin increased, associated with males, older age and low clinical stage. Polycythemia
52
Symptoms of Thrombocytosis
Headache. Dizziness or lightheadedness. Chest pain. Weakness. Bloody stools Numbness or tingling of the hands and feet. Skin bruising easily. Bleeding from places like the nose, mouth and gums. Bleeding in the stomach or intestinal tract Blood clots in arteries and veins, most often in the hands, feet, and brain Swollen lymph nodes
53
Patterns of Spread of Wilm's Tumor
Locally – grow into the renal sinus or ureter Contiguous spread through renal vein into IVC and rarely R atrium Regional lymph node involvement Haematogenous spread Lungs(80%) Liver(15%) Rarely bone, bone marrow or brain
54
Wilm's tumor staging
Stage I ... confined to one kidney Stage II ... through capsule Stage III ... residual tumour (after biopsy) Stage IV ... metastatic disease Stage V ... bilateral disease (you'll need to stage both kidney's separately)
55
Investigations for Wilm's tumor
History –Fhx of cancer, congenital defects p/e congenital abnormalities FBC Urinalysis and renal function LDH, uric acid, clotting screen (because of acquired von willebrand disease) Echo - if you want to give doxorubicin for mets disease Abdominal USG/CT/MRI (better delineation) Chest x-ray/CT scan (CT better for chest, can pick up small nodules)
56
Wilm's Tumor Treatment
Neoadjuvant/Adjuvant chemotherapy Surgery (primary or delayed) for all - In Ghana, Chemotherapy, Surgery, Radiotherapy if indicated, Chemotherapy Chemotherapy Stage I or II: Vincristine + Dactinomycin Stage III or IV: Add DOXORUBICIN RENAL BED RADIOTHERAPY for local Stage III PULMONARY RADIOTHERAPY for lung metastases
57
What are the other renal tumors of childhood?
Nephroblastomatosis – Nephrogenic rests that are potential precursors of Wilms Tumour. Congenital mesoblastic nephroma (In children <3 months) Clear cell sarcoma of the kidney- 3-5yrs. Metastasize to the bone, lung, liver and brain Rhabdoid tumour of the kidney. (presents by 1 yr, Poor prognosis with mortality of 80%). Patients have hypercalcemia Renal cell carcinoma – mostly adolescents
58
What are nephrogenic rests?
Abnormally persistent clusters of embryonal cells, representing microscopic malformations (dysplasias) of the developing kidney.
59
What is retinoblastoma and how does it grow?
It is a malignant tumor of the embryonic neural retina. Starts as an intraocular growth occurs, prior to invasion of structures within the globe or spread to metastatic sites.
60
What age group is affected by retinoblastoma?
Children <5 years of age
61
Incidence of Retinoblastoma
Most common intraocular malignant tumour Occurs 1 in 20,000 live births Annual incidence is 10-14 per million under 5yrs of age 11% of cancers in 1st year of life 3% of cancers diagnosed in children < 15yrs Average age at diagnosis is 18mths
62
What are the signs and symptoms of Retinoblastoma?
Leukocoria. Strabismus - squint Proptosis Decreased visual acuity. Inflammatory changes in eye. Hyphema. Vitreous hemorrhage, resulting in a black pupil.
63
How is retinoblastoma classified?
3 overlapping methods Laterality- unilateral (2yrs) or bilateral (1yr), Trilateral Focality - unifocal or multifocal Genetics- hereditary(40%) or non-hereditary(60%)
64
Trilateral retioblastoma
Well recognized syndrome that occurs in children under the age of 5 years Usually consists of bilateral hereditary retinoblastoma associated with an intracranial neuroblastic tumour of the pineal gland Occurs in about 5 – 15% of children with familial, multifocal or bilateral retinoblastoma
65
How is Screening for Retinoblastoma done
Eliciting red reflexes in the eye as part of the well child check ups Siblings of children with retinoblastoma should be screened by ophthalmology at regular intervals at least through age 3 yrs. Siblings of patients should be screened for mutations in the RB1 gene.
66
How is Diagnosis of Retinoblastoma made?
CT, or MRI scan of brain and orbit Due to concern about rupturing the tumor and causing both intraocular and extraocular spread, surgical biopsies are not performed for confirmation.
67
Investigations for Retinoblastoma
FBC BUE and Creatinine Lumbar puncture if there is radiographic or clinical suspicion of CNS disease (CSF Cytology) Bone marrow biopsy when there is abnormal blood counts Histopathologic evaluation if enucleation is performed (usually after chemotherapy to reduce size of tumor)
68
Modalities of treatment of Wilms Tumor
Single used or combined modality approach is not uncommon: Systemic chemotherapy External beam radiotherapy Local ophthalmic therapy(laser Ry or Cryotherapy) Intra-arterial chemotherapy, using an interventional neuro-radiology approach Enucleation.
69
Secondary Malignancies of Retinoblastoma
OSTEOSARCOMA SOFT TISSUE SARCOMAS MELANOMA LEUKAEMIA LYMPHOMA BREAST CANCER
70
What is a neuroblastoma?
Malignant tumour of peripheral sympathetic nervous system that develops from immature nerve cells(neural crest)
71
Most common cancer in infancy//Commonly arises where//Common in which groups of people
Neuroblastoma Commonly arises in and around adrenal glands More common in boys than girls
72
Sites for neuroblastoma
Sympathetic chain Neck Thorax - posterior mediastinal neuroblastoma Retroperitoneum - of adrenal medulla origin//Paraspinal ganglion origin Pelvis Adrenal gland
73
Clinical Presentation of neuroblastoma
Constitutional Symptoms: Anorexia, Weight loss, Malaise, fever Pain (most common), due to local spread &/or metastatic disease Abdominal lump Respiratory compromise: from mediastinal mass Esp in young infants with massive hepatomegaly Horner's syndrome(neck mass), spinal cord compression, Cytopenias (marrow involvement), Blueberry muffin sign (skin involvement). Bowel/bladder dysfunction (pelvic mass), opsoclonus-myoclonus syndrome (truncal ataxia and cerebellar encephalopathy) Proptosis/ecchymoses: Orbital mets
74
Other syndromes associated with Neuroblastoma
Pepper syndrome – Neuroblastoma of adrenal gland with metastases in the liver Hutchinson syndrome – Limping and irritability due to skeletal metastases Horner syndrome – Miosis, ptosis , anhidosis
75
Investigations for Neuroblastoma
FBC, LDH, LFT, RFT, Uric acid 24hr Urine VMA and HVA - specific investigation Xray – calcified abdominal or posterior mediastinal mass USG CT or MRI Bone Scan MIBG- meta-iodobenzylguanidine scan Bone marrow aspirate Biopsy
76
Treatment of Neuroblastoma
Chemotherapy – COJEC (Cisplatin, Oncovin/Vincristine, Carboplatinum, Etoposide, Cyclophosphamide) Surgery Radiation High dose chemotherapy/radiation/stem cell transplant Cis-retinoic acid - to consolidate/maintain KEDO - In pallative setting Cyclophosphamide, Vincristine, Doxorubicin
77
Give some facts about brain tumors
50-60% of paediatric brain tumours occur in the posterior fossa (below the tentorium) Tumours with similar histology can arise in different areas of the CNS so it’s most useful to consider them according to cell of origin. Untreated brain tumours are fatal regardless of whether the histology is low grade (“benign” / “dysplastic”) or high grade (“malignant”)
78
How are brain tumors classified?
Embryonal (primitive neuroectodermal tumours) Medulloblastomas / Supratentorial PNETS Pinealoblastomas (Atypical Teratoid / Rhabdoid Tumours) Glial Tumours Glioblastomas Astrocytomas Oligodendrogliomas Ependymomas Craniopharyngioma Germ Cell Tumour Pituitary Adenoma
79
Aetiology of Brain Tumors
Radiation therapy is the only known exogenous cause! Increased incidence with certain syndromes Neurofibromatosis 1: low grade gliomas (especially optic pathway) Tuberous Sclerosis: subependymal giant astrocytomas Sturge-Weber: meningeal and cortical angiomas Familial syndromes: Li Fraumeni … gliomas Gorlin / Turcot’s medulloblastomas
80
Clinical Presentation of Brain Tumors
INFRATENTORIAL OR SUBTENTORIALLY Cerebellar signs (ataxia) Cranial nerve palsies (esp. bulbar) Hemiplegia Headaches (nausea and vomiting) - anything obstructing v4 SUPRATENTORIALLY Focal Neurology ex Hemispheric lesions Hemianopia and Hormonal dysfunction ex tumours occuring in the Suprasellar region
81
Management of patients with Brain Tumor
Hydrocephalus VP shunts were associated with multiple complications Less of a problem with the advent of the third ventriculostomy Steroids for relief of raised ICP and occasionally focal neurology Dexamethasone at minimum effective dose Bulbar Palsy May require NG tube feeding or occasionally justify a PEG Physio / Occupational Therapy / Neurodevelopmental rehab is crucial ADEQUATE ANALGESIA in the palliative care setting!
82
Management Principles for Brain Tumor
Surgery Shunting, Surgical excision - Gross total excision Radiotherapy Chemotherapy
83
Define Late Effects of Cancer
Any physical or psychological outcome that develops or persists beyond 5 years from the diagnosis of cancer
84
What causes late effects of cancer? What is the prognosis of these effects
*Chemotherapy, radiation therapy and surgery may all cause late effects *Some late effects of therapy identified during childhood or adolescence resolve without consequences, while other late effects become chronic and progress to become adult medical problems
85
Long Term Growth and Development effects, Cancer effects
Skeletal maturation Linear growth Emotional & social maturation Intellectual function Sexual development Cancer effects Recurrent primary cancer Subsequent neoplasms
86
Long term effects of Cancer on organs/Fertility and reproduction
Cardiac\Endocrine/GI & Hepatic/Genitourinary/Musculoskeletal/Neurological/Pulmonary Fertility & Reproduction Fertility Health of Offspring Sexual functioning
87
Long term effects of cancer on Psychosocial health
Mental Health Education Employment Health Insurance Chronic symptoms Physical/Body Image
88
Long Term Effects of Radiation
Neurocognitive IQ and performance reduced Endocrine GH and thyroid hormone def Infertility Precocious puberty ACTH deficiency Obesity , GH def with hypothalamic obesity Neurologic Hearing loss Neuropathy Ataxia and motor defects Second cancers Leukaemias and brain tumours Vascular, Cerebro Moyamoya and microhaemorhages
89
Leukemia definition
a group of malignant diseases in which genetic abnormalities in a haemotopoietic cell give rise to an unregulated clonal proliferation of cells; resulting in a disruption of normal marrow function and ultimately marrow failure.
90
What is the most common malignant neoplasm in childhood?
Leukemia - accounts for 31% of all malignancies that occur in children less than 15 years.
91
What is the most common hematopoietic tumor of childhoood?
Acute Lymphoblastic leukemia
92
Peak incidence of ALL
Peak incidence between 2-5years
93
Predisposing syndromes of ALL + % of blasts in bone marrow
Down Syndrome, NF 1, Bloom Syndrome, Ataxia Telangectasia 25% blasts in bone marrow
94
How does ALL occur?
95
How does ALL occur?
Proliferation of immature lymphoid cells or lymphoblasts.
96
Symptoms and Signs of ALL - General and hematologic effects
General systemic effects Fever, lassitude and pallor. Haematologic effects from bone marrow invasion Anaemia – pallor, irritability, decreased activity, Neutropenia - fevers Thrombocytopenia – petechiae, ecchymosis, epistaxis, DIC
97
Symptoms and Signs of ALL - Lymphoid system infiltration
Lymphoid System Infiltration Lymphadenopathy, splenomegaly and hepatomegaly. Testicular involvement Renal involvement- haematuria, hypertension and renal failure. GI manifestations- bleeding Bone and joint involvement- bone pain. Leukaemic infiltration of the periosteum, bone infarction or expansion of marrow cavity by leukaemic cells.
98
Signs and Symptoms of ALL - CNS Involvement
CNS involvement Raised ICP(headache, morning vomiting, VI nerve palsy. Focal neurologic signs- convulsions, ataxia, dysmetria etc Hypothalamic syndrome (polyphagia, excessive wt gain, hirsutism) Chloromas of the spinal cord-back pain, numbness, weakness. CNS haemorrhage- leukostasis, leukothrombi-infarcts-haemorrhage (coagulopathy)
99
What is Febrile Neutropenia? Describe the types
Temp > 37.50C on 2 occasions 30mins apart or > 38.30C with Neutropenia: ANC (Absolute neutrophil count) < 1500 cells / mm3 Mild Neutropenia: 1000-1500 cells / mm3 Moderate Neutropenia: 500-999 cells / mm3 Severe Neutropenia: < 500 cells / mm3 Profound Neutropenia: <100 cells/ mm3
100
What are the infection Precautions for febrile neutropenia?
All persons should perform hand hygiene before entering and after leaving the patient’s room “Neutropenic diet” (ie, well-cooked foods) Oral hygiene (toothbrushing(soft) at least twice per day; oral rinses at least four times per day; Daily showers or baths Daily inspection of skin sites that may be portals of infection (eg, perineum, sites of intravascular access) Avoidance of rectal procedures (eg, thermometry, enemas, suppositories, PR examinations) Prevent constipation in patients. Antimicrobial stewardship
101
Aetiology for Childhood Cancers
idiopathic in most cases (interaction between environmental factors (e.g. viral infection) and host genetic susceptibility. Inherited in 10-15% of cases (RB gene mutation – bilateral Retino) Childhood syndromes – Down syndrome and Leukaemia, NF1 and gliomas Infection related –EBV – Burkitts lymphoma, Hodgkins lymphoma, Nasopharyngeal Carcinoma. Kaposi Sarcoma – HIV and Human herpes 8 virus Burkitts lymphoma – HIV and Malaria Others – Radiation (leukemia), chemotherapy, commercial pesticide use (farming, Burkitt's) etc Malaria - Burkitt's Lymphoma
102
SILUAN Signs
Early warning signs for Cancer S: Seek help for persistent signs I: Eye - White spot, new onset squint, impaired vision, persistent reddening, bulging eyeball L: Lumps - swelling/lumps in any part of the body U: Unexplained: Fever>2 weeks, pallor, tiredness, easy bruising, loss of weight A: Aches - Persistent breaks in bones and joints, bones that break easily. N; Neurological - Change in walking, balance or speech, headache for more than a week with or without vomiting, enlarging head.
103
Tumor Markers and Pathology for Childhood cancer
VMA and HVA for neuroblastoma. High α-fetoprotein (αFP) in germ cell tumours and liver tumours Biopsy for solid tumours and BMA for Leukaemia
104
Targeted drug therapy and Immunotherapy
Targeted drug therapy eg Imatinib - Tyroxine Kinase inhibitor - In patients with CML, Rituximab - CD20 inhibitor for Burkitt's lymphoma Immunotherapy eg Car-T Cell Therapy for Leukemia
105
Treatment strategies in Chemotherapy
Adjuvant: short course of high dose, usually combination drugs given after rad. or surg. Neoadjuvant: adjuvant drugs used pre- or perioperative period Palliative: given to improve quality of life or control symptoms if cure is not possible Salvage: curative high dose given when symptoms have recurred or treatment has failed with another regimen
106
Treatment strategies in Chemotherapy
Adjuvant: short course of high dose, usually combination drugs given after rad. or surg. Neoadjuvant: adjuvant drugs used pre- or perioperative period Palliative: given to improve quality of life or control symptoms if cure is not possible Salvage: curative high dose given when symptoms have recurred or treatment has failed with another regimen
107
Short Term Side effects of chemotherapy
Anaemia Thrombocytopenia Bleeding Neutropenia -can lead to infection Undernutrition Aloepecia
108
Side effects of Chemotherapy
Mucositis Nausea/vomiting Diarrhoea Cystitis Sterility Neuropathy Alopecia Cardiotoxiciy Local reaction Renal failure Myelosupression Phlebitis